Biopharma industry eyes 2025 bounceback, grapples with uncertainty over Trump return
By Deena Beasley SAN FRANCISCO (Reuters) – The biopharmaceutical industry is aiming for a 2025 reversal of last year’s slump in investor returns
By Deena Beasley SAN FRANCISCO (Reuters) – The biopharmaceutical industry is aiming for a 2025 reversal of last year’s slump in investor returns
By Ryan Patrick Jones (Reuters) – Canadian Prime Minister Justin Trudeau will hold a cabinet retreat on Jan. 20-21 focused on defending his
BUENOS AIRES (Reuters) -Argentine monthly inflation ticked up slightly in December, data showed on Tuesday, though the annual rate continued to slow
WASHINGTON (Reuters) – The U.S. government posted an $87 billion budget deficit in December, reduced partly by a shift of benefit payments
(Reuters) – Asset manager BlackRock (NYSE:BLK)’s top executive Mark Wiedman, who was touted to be a potential successor to CEO Larry Fink,
WASHINGTON (Reuters) – Democratic lawmakers on the U.S. Senate Energy Committee called Tuesday on the panel’s Republican chairman to postpone the confirmation
Investing.com — Mark Wiedman, a top executive at BlackRock Inc (NYSE:BLK)., and potential successor to CEO Larry Fink, has decided to leave
Investing.com — Stephens began coverage of Mister Car Wash Inc (NYSE:MCW) with an “Equal-Weight” rating and a price target of $8
By Nicole Jao and Shariq Khan NEW YORK (Reuters) -Colonial Pipeline, the largest refined products pipeline operator in the United States, said on
On Tuesday, Kymera Therapeutics shares leaped 12% following the biotechnology firm’s update on its product pipeline. The New York-based company announced progress